查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945436

2026年全球关节疼痛注射市场报告

Joint Pain Injections Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，注射关节止痛药物的市场规模迅速扩张，预计将以12.5%的复合年增长率成长，从2025年的61.2亿美元成长到2026年的68.9亿美元。过去几年的成长被认为归因于多种因素，例如关节炎和关节疾病的盛行率不断上升、全球人口老化、对微创疼痛治疗的需求不断增长、人们对再生医学的认识不断提高以及专业整形外科护理的扩展。

预计未来几年关节疼痛注射剂市场将快速成长，到2030年市场规模将达到109.6亿美元，复合年增长率（CAGR）为12.3%。预测期内的增长可归因于生物镇痛治疗方法的日益普及、对个人化医疗的日益关注、运动损伤管理的扩展、再生医学投资的增加以及对非阿片类镇痛疗法的偏好日益增强。预测期内的主要趋势包括：非手术镇痛疗法的日益普及、透明质酸和富血小板血浆（PRP）注射疗法的广泛应用、对个性化镇痛方案需求的增长、基于再生医学的注射疗法的扩展以及对门诊病人镇痛方案的日益重视。

关节炎和肌肉骨骼疾病的日益普遍预计将推动关节疼痛注射市场的发展。肌肉骨骼疾病是全球造成残疾的主要原因之一，其中腰痛是160个国家最常见的残疾原因。患者越来越依赖注射疗法来控制疼痛和治疗发炎性疾病。例如，美国独立医学研究机构—健康指标与评估研究所（IHME）于2023年8月发布报告称，预计到2050年，全球将有约10亿人患有骨关节炎。因此，关节炎和肌肉骨骼疾病负担的加重正在推动关节疼痛注射市场的需求。

关节疼痛注射剂市场的主要企业正致力于创新研发，例如优先考虑患者便利性的单次注射製剂。单次注射製剂是一种药物传递系统，只需一次注射即可输送特定的活性成分，无需多次给药即可在较长时间内提供持续的治疗效果。例如，2024年7月，韩国化学公司LG化学在中国推出了用于治疗膝关节骨性关节炎的新型药物Synovian。该产品采用便利的单次注射製剂，是中国首款此类产品。该产品旨在占据一个预计价值约2,000亿韩元（约1.5亿美元）的庞大市场。该产品采用专有技术开发，专注于以最小的给药负担提供有效的缓解，展现了满足患者需求的创新理念。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球关节疼痛注射剂市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 永续性、气候技术和循环经济
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 非手术疼痛管理疗法的采用率不断提高
    • 玻尿酸和富血小板血浆注射的使用增加
    • 对个人化疼痛治疗方法的需求日益增长
    • 基于再生医学的注射疗法的拓展
    • 人们越来越关注门诊病人疼痛缓解方案

第五章 终端用户产业市场分析

  • 医院
  • 整形外科诊所
  • 疼痛管理中心
  • 运动医学诊所
  • 门诊治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球关节疼痛注射剂市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球关节疼痛注射市场规模、对比及成长率分析
  • 全球关节疼痛注射市场表现：规模与成长，2020-2025年
  • 全球关节疼痛注射市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 注射型
  • 类固醇关节注射，玻尿酸注射
  • 按关节类型
  • 髋关节、膝关节和踝关节、肩关节和肘关节、脊椎椎间关节以及其他类型的关节
  • 透过分销管道
  • 医院药房、零售药房
  • 按类型细分：类固醇关节注射
  • 皮质类固醇注射，合併类固醇注射
  • 按类型细分：透明质酸注射剂
  • 单次注射玻尿酸，多剂量注射玻尿酸

第十章 区域与国家分析

  • 全球关节疼痛注射市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球关节疼痛注射市场：按国家、绩效和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 关节疼痛注射市场：竞争格局及市场占有率（2024年）
  • 关节疼痛注射市场：公司估值矩阵
  • 关节疼痛注射市场：公司概况
    • Seikagaku Corporation
    • Anika Therapeutics Inc.
    • Bioventus Inc.
    • Flexion Therapeutics Inc.
    • Ferring Pharmaceuticals Inc.

第37章：其他领先和创新企业

  • Sanofi SA, AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan NV, Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年关节疼痛注射市场：提供新机会的国家
  • 2030年关节疼痛注射市场：充满新机会的市场区隔
  • 2030年关节疼痛注射市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MJPIA01_G26Q1

Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs are influencing the joint pain injections market by increasing costs of imported biologics, syringes, processing equipment, and cold-chain packaging materials. Orthopedic clinics and hospitals in North America and Europe are most affected due to reliance on imported injectable formulations, while Asia-Pacific faces cost pressure on biologic production inputs. These tariffs are increasing treatment costs and limiting accessibility for some patients. However, they are also encouraging local biologics manufacturing, regional formulation development, and innovation in cost-efficient injectable therapies.

The joint pain injections market research report is one of a series of new reports from The Business Research Company that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown rapidly in recent years. It will grow from $6.12 billion in 2025 to $6.89 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing prevalence of arthritis and joint disorders, aging global population, rising demand for minimally invasive pain treatments, growing awareness of regenerative therapies, expansion of orthopedic specialty care.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $10.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing adoption of biologic pain therapies, rising focus on personalized medicine, expansion of sports injury management, growing investments in regenerative medicine, increasing preference for non-opioid pain management. Major trends in the forecast period include increasing adoption of non-surgical pain management therapies, rising use of hyaluronic acid and prp injections, growing demand for personalized pain treatment approaches, expansion of regenerative medicine-based injections, enhanced focus on outpatient pain relief solutions.

The increasing prevalence of arthritis and musculoskeletal disorders is expected to drive growth of the joint pain injections market. Musculoskeletal disorders represent the leading cause of disability globally, with low back pain being the most common cause of impairment across 160 countries. Patients increasingly rely on injections for pain management and treatment of inflammatory conditions. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a U.S.-based independent health research organization, reported that nearly one billion people are projected to be living with osteoarthritis by 2050. Therefore, the growing burden of arthritis and musculoskeletal disorders is fueling demand in the joint pain injections market.

Leading companies in the joint pain injections market are concentrating on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is a type of drug delivery system designed to deliver a specific dose of medication in a single injection, offering sustained therapeutic effects over an extended period without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, introduced Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. The product aims to capture a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it demonstrates innovation in meeting patient needs, focusing on providing effective relief with minimal administration effort.

In July 2025, Johnson & Johnson MedTech, a U.S.-based provider of medical devices and healthcare solutions, partnered with Pacira BioSciences to expand early-intervention options for knee osteoarthritis. Through this collaboration, both companies aim to increase market adoption of ZILRETTA(TM), a triamcinolone acetonide extended-release injectable, improve product accessibility, and strengthen presence in the knee osteoarthritis segment. Pacira BioSciences is a U.S.-based specialty pharmaceutical company that develops and commercializes non-opioid pain management and local analgesic products, including intra-articular injections for joint pain.

Major companies operating in the joint pain injections market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus Inc., Flexion Therapeutics Inc., Ferring Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited, AstraZeneca plc

North America was the largest region in the joint pain injections market in 2025. The regions covered in the joint pain injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Joint Pain Injections Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for joint pain injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The joint pain injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections
  • 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types
  • 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies
  • Subsegments:
  • 1) By Steroid Joint Injection: Corticosteroid Injections; Combination Steroid Injections
  • 2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections; Multi-Dose Hyaluronic Acid Injections
  • Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus Inc.; Flexion Therapeutics Inc.; Ferring Pharmaceuticals Inc.; Sanofi S.A.; AbbVie Inc.; Pfizer Inc.; Teva Pharmaceutical Industries Limited; Merck & Co. Inc.; Johnson & Johnson; Sun Pharmaceutical Industries Ltd.; Zydus Lifesciences Limited; Wockhardt Ltd.; Mallinckrodt Pharmaceuticals Ltd.; Mylan N.V.; Bayer AG; Eli Lilly and Company; Ipsen SA; Takeda Pharmaceutical Company Limited; AstraZeneca plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Joint Pain Injections Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Joint Pain Injections Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Joint Pain Injections Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Joint Pain Injections Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Sustainability, Climate Tech & Circular Economy
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Non-Surgical Pain Management Therapies
    • 4.2.2 Rising Use Of Hyaluronic Acid And Prp Injections
    • 4.2.3 Growing Demand For Personalized Pain Treatment Approaches
    • 4.2.4 Expansion Of Regenerative Medicine-Based Injections
    • 4.2.5 Enhanced Focus On Outpatient Pain Relief Solutions

5. Joint Pain Injections Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Orthopedic Clinics
  • 5.3 Pain Management Centers
  • 5.4 Sports Medicine Clinics
  • 5.5 Ambulatory Care Centers

6. Joint Pain Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Joint Pain Injections Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Joint Pain Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Joint Pain Injections Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Joint Pain Injections Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Joint Pain Injections Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Joint Pain Injections Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Joint Pain Injections Market Segmentation

  • 9.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Steroid Joint Injection, Hyaluronic Acid Injections
  • 9.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
  • 9.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies
  • 9.4. Global Joint Pain Injections Market, Sub-Segmentation Of Steroid Joint Injection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Corticosteroid Injections, Combination Steroid Injections
  • 9.5. Global Joint Pain Injections Market, Sub-Segmentation Of Hyaluronic Acid Injections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections

10. Joint Pain Injections Market Regional And Country Analysis

  • 10.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Joint Pain Injections Market

  • 11.1. Asia-Pacific Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Joint Pain Injections Market

  • 12.1. China Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Joint Pain Injections Market

  • 13.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Joint Pain Injections Market

  • 14.1. Japan Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Joint Pain Injections Market

  • 15.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Joint Pain Injections Market

  • 16.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Joint Pain Injections Market

  • 17.1. South Korea Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Joint Pain Injections Market

  • 18.1. Taiwan Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Joint Pain Injections Market

  • 19.1. South East Asia Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Joint Pain Injections Market

  • 20.1. Western Europe Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Joint Pain Injections Market

  • 21.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Joint Pain Injections Market

  • 22.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Joint Pain Injections Market

  • 23.1. France Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Joint Pain Injections Market

  • 24.1. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Joint Pain Injections Market

  • 25.1. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Joint Pain Injections Market

  • 26.1. Eastern Europe Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Joint Pain Injections Market

  • 27.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Joint Pain Injections Market

  • 28.1. North America Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Joint Pain Injections Market

  • 29.1. USA Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Joint Pain Injections Market

  • 30.1. Canada Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Joint Pain Injections Market

  • 31.1. South America Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Joint Pain Injections Market

  • 32.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Joint Pain Injections Market

  • 33.1. Middle East Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Joint Pain Injections Market

  • 34.1. Africa Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Joint Pain Injections Market Regulatory and Investment Landscape

36. Joint Pain Injections Market Competitive Landscape And Company Profiles

  • 36.1. Joint Pain Injections Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Joint Pain Injections Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Joint Pain Injections Market Company Profiles
    • 36.3.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Bioventus Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Ferring Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Joint Pain Injections Market Other Major And Innovative Companies

  • Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited

38. Global Joint Pain Injections Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Joint Pain Injections Market

40. Joint Pain Injections Market High Potential Countries, Segments and Strategies

  • 40.1 Joint Pain Injections Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Joint Pain Injections Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Joint Pain Injections Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer